Morepen Laboratories Limited

rs,

Subject: Investor Presentation – Q4 & FY26 Dear Sir/ Madam, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001 Scrip Code: 500288 Please find enclosed the Investor Presentation –

Rs. 823

ial Program Milestones Achieved Commercial Program Milestones Achieved Secured multi-year mandate (Rs. 823cr) Secured multi-year mandate (Rs. 823cr) multi-year mandate (Rs. 823cr) Secured Commercial produc

11%

enefits ✔✔ Operating leverage benefits Operating leverage benefits Exisitng Exisitng Exisitng 10-11% EBITDA Range 10-11% EBITDA Range 10-11% EBITDA Range Mid -term Mid -term Mid -term Path toward 20

20%

1% EBITDA Range 10-11% EBITDA Range 10-11% EBITDA Range Mid -term Mid -term Mid -term Path toward 20%+ EBITDA profile Path toward 20%+ EBITDA profile Path toward 20%+ EBITDA profile Long-term Long-te

22%

e Growth Q4- Revenue Growth Revenue Momentum Revenue Momentum Revenue Momentum Q4 FY26 revenue up 22% YoY to Rs. 472 Cr Q4 FY26 revenue up 22% YoY to Rs. 472 Cr Q4 FY26 revenue up 22% YoY to Rs. 472 Cr

Rs. 472

- Revenue Growth Revenue Momentum Revenue Momentum Revenue Momentum Q4 FY26 revenue up 22% YoY to Rs. 472 Cr Q4 FY26 revenue up 22% YoY to Rs. 472 Cr Q4 FY26 revenue up 22% YoY to Rs. 472 Cr API-Q4 growth

17%

Q4 FY26 revenue up 22% YoY to Rs. 472 Cr Q4 FY26 revenue up 22% YoY to Rs. 472 Cr API-Q4 growth of 17% API-Q4 growth of 17% API-Q4 growth of 17% Medical Devices -Q4 growth of 31% Medical Devices -Q4 gr

31%

2 Cr API-Q4 growth of 17% API-Q4 growth of 17% API-Q4 growth of 17% Medical Devices -Q4 growth of 31% Medical Devices -Q4 growth of 31% Medical Devices -Q4 growth of 31% FY26 growth of 8% FY26 growth

8%

4 growth of 31% Medical Devices -Q4 growth of 31% Medical Devices -Q4 growth of 31% FY26 growth of 8% FY26 growth of 8% FY26 growth of 8% CDMO & Manufacturing Update Update CDMO & Manufacturing Updat

70%

gnment toward large customer engagements Capacity alignment toward large customer engagements Over 70% Export Business, Over 80% repeat customers Over 80% repeat customers Over 70% Export Business, Over

80%

er engagements Capacity alignment toward large customer engagements Over 70% Export Business, Over 80% repeat customers Over 80% repeat customers Over 70% Export Business, Over 80% repeat customers Over

500 MT

pacity’ for on boarding new customers Building 20% ‘ready capacity’ for on boarding new customers ~500 MT manufacturing and delivery scale ~500 MT manufacturing and delivery scale ~500 MT manufacturing and